AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $41.66M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Last update - 15.57pm 31/07/2026 (20 minute delay)
?
| Day | ||||||||
|---|---|---|---|---|---|---|---|---|
| Open | 3.6¢ | Day High | 3.8¢ | Day Low | 3.6¢ | |||
| Daily Volume | 244679 | |||||||
| Bids | Sellers | |||||
|---|---|---|---|---|---|---|
| Number | Price | Volume | Number | Price | Volume | |
| 0 | 3.6¢ | 250377 | 0 | 3.8¢ | 276585 | |
Directors & Senior Management
| Dr. Adam L. Myers | Chairman of the Commercial Scientific Advisory Board |
| Ms. Anoushka Gungadin | MD, CEO & Director |
| Mr. Cameron Peter Jones | CFO & Company Secretary |
| Ms. Cheryle Royle | Member of Advisory Board |
| Mr. David Hinton | Independent Non-Executive Director |
| Henry Jordan | Head of Investor Relations |
| Mr. Jeff Garibaldi | Chief Growth Officer |
| Dr. Mandy Khaira | Chief Clinical Transformation Officer & Chief Medical Officer |
| Ms. Nicole Zappala | Head of Customer Success |
| Dr. Paul A. Friedman | Member of Advisory Board |
| Dr. Sharon Howell Richardson | Chairman of Advisory Board & Director |
| Ms. Stephanie Vipond | Joint Company Secretary |
| Mr. Timothy Chapman | Independent Non-Executive Chairman |
| Mr. Vivek Krishnan | Chief Technology Officer |
Data source: ADVFN
